European Journal of Medicinal Chemistry p. 53 - 67 (2016)
Update date:2022-08-15
Topics:
Thaler, Florian
Moretti, Loris
Amici, Raffaella
Abate, Agnese
Colombo, Andrea
Carenzi, Giacomo
Fulco, Maria Carmela
Boggio, Roberto
Dondio, Giulio
Gagliardi, Stefania
Minucci, Saverio
Sartori, Luca
Varasi, Mario
Mercurio, Ciro
In the last decades, inhibitors of histone deacetylases (HDAC) have become an important class of anti-cancer agents. In a previous study we described the synthesis of spiro[chromane-2,4′-piperidine]hydroxamic acid derivatives able to inhibit histone deacetylase enzymes. Herein, we present our exploration for new derivatives by replacing the piperidine moiety with various cycloamines. The goal was to obtain highly potent compounds with a good in vitro ADME profile. In addition, molecular modeling studies unravelled the binding mode of these inhibitors.
View Morewebsite:http://www.cartoonchem.com/
Contact:+86-25-58074918
Address:Room 2109, RuiHua Business Center,315 South ZhongShan Road, Nanjing 210001, China
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Hangzhou Maytime Bio-Tech Co.,Ltd.
website:http://www.maytime.com.cn
Contact:+86-571-88925295 88920965
Address:NO.2-1701 Ganghui Central Ningwei Street, Xiaoshan Hangzhou Zhejiang China
Skyrun Industrial Co.,Ltd(expird)
website:http://www.chinaskyrun.com
Contact:0086-576-84610586
Address:Chemical Development Zone
Shanghai Rainbow Chemistry Co., Ltd.
Contact:+86-21-64968086-5815/5812
Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
Doi:10.1007/BF00808927
(1990)Doi:10.1016/S0040-4039(00)94563-5
(1990)Doi:10.3184/174751911X13052910926808
(2011)Doi:10.1021/ja200712f
(2011)Doi:10.1007/s00044-011-9600-x
(2012)Doi:10.1016/j.molstruc.2011.01.006
(2011)